Psychopharmacology and Psychiatry Updates

Un pódcast de Psychopharmacology Institute

Categorías:

213 Episodo

  1. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Publicado: 29/9/2021
  2. How to Assess Psychotropic Drug Adherence

    Publicado: 24/9/2021
  3. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Publicado: 19/9/2021
  4. Delirium, Catatonia, and COVID-19

    Publicado: 14/9/2021
  5. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Publicado: 9/9/2021
  6. Dopamine and Depression: Clinical Considerations

    Publicado: 4/9/2021
  7. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Publicado: 30/8/2021
  8. New Somatic Treatments for Child and Adolescent Depression

    Publicado: 25/8/2021
  9. Management of Delirium: Nonpharmacologic Strategies

    Publicado: 20/8/2021
  10. Emerging Complementary and Integrative Therapies for Geriatric Mental Health

    Publicado: 15/8/2021
  11. Delirium: Assessment, Consequences, and Sequelae

    Publicado: 10/8/2021
  12. In Search of a Dose-Response Relationship in SSRIs

    Publicado: 5/8/2021
  13. Valproate/Divalproex: Metabolism, Kinetics, and Warnings

    Publicado: 31/7/2021

11 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site